Brief: Beta Drugs Receives Drug Controller General Of India Nod To Launch Enzalutamide 160Mg
24/03/2023 07:48
March 24 (Reuters) - Beta Drugs Ltd BTAD.NS :
* RECEIVES DRUG CONTROLLER GENERAL OF INDIA NOD TO LAUNCH
ENZALUTAMIDE 160MG WITH BRAND NAME ADLEAP
Source text for Eikon: ID:nNSEb7W4MH
Further company coverage: BTAD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beta Drugs
See all newsBrief: Beta Drugs Receives Oncology Portfolio Approvals In Azerbaijan
India's Beta Drugs jumps after regulatory milestones in Azerbaijan, Philippines
Brief: Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines
Brief: Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees
Brief: Beta Drugs Receives Dcgi Approval For Methotrexate Oral Solution